跳至主要内容
临床试验/NL-OMON55459
NL-OMON55459招募中3 期

Protocol for treatment of children and adolescents with acute myeloid leukemia 0-18 years - NOPHO-DBH AML 2012 Protocol

Västra Götalandregionen, Queen Silvias Childrens and Adolescents Hospital0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 至 64(—)

入选标准

  • Patients are eligible for the study if they fulfil all three criteria below, 1)
  • AML as defined by the diagnostic criteria in section 16
  • 2) Age < 19 years at time of diagnosis
  • 3) Written informed consent

排除标准

  • Patients are excluded if any of the criteria below are present
  • 1) Previous chemotherapy or radiotherapy.
  • 2) AML secondary to previous bone marrow failure syndrome.
  • 3) Down syndrome (DS).
  • 4) Acute promyelocytic leukaemia (APL).
  • 5) Myelodysplastic syndrome (MDS).
  • 6) Juvenile Myelomonocytic Leukaemia (JMML).
  • 7) Known intolerance to any of the chemotherapeutic drugs in the protocol.
  • 8) Fanconi anaemia.
  • 9) Major organ failure precluding administration of planned chemotherapy.
  • 10) Positive pregnancy test.

研究者

发起方
Västra Götalandregionen, Queen Silvias Childrens and Adolescents Hospital

相似试验